These medications have seen an explosion in sales with the approval and off-label use for weight loss, typically resulting in a reduction in body weight of 15-21% when combined with nutrition and exercise
The study is a review or a case study

Ingredients/Material Onsen-Sui, Water, Butylene Glycol, Glycerin, Propylene Glycol Dicaprylate, Titanium Dioxide, Cyclopentasiloxane, Sodium Hyaluronate, Pentaerythrityl Tetraethylhexanoate, Niacinamide, PEG-10 Dimethicone, Dimethicone, Cyclohexasiloxane, 1,2-Hexanediol, Phenyl Trimethicone, Caprylyl Glycol, Ammonium Acryloyldimethyltaurate/VP Copolymer, Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Glutathione, Persea Gratissima (Avocado) Oil, Allantoin, Pentylene Glycol, Isohexadecane, Thuja Orientalis Leaf Extract, Zanthoxylum Schinifolium Leaf Extract, Polygonum Cuspidatum Root Extract, Aloe Barbadensis Leaf Powder, Centella Asiatica Extract, Scutellaria Baicalensis Root Extract, Camellia Sinensis Leaf Extract, Glycyrrhiza Glabra Root Extract, Chamomilla Recutita Flower Extract, Rosmarinus Officinalis Leaf Extract, Simmondsia Chinensis Seed Oil, Ethylhexylglycerin, Adenosine, Dipotassium Glycyrrhizate, Polysorbate 80, Aspalathus Linearis Extract #wskinlaboratory #whiteglutathionetoneupcream #glutathionecream #toneupcream #brighteningcream #wrinklecarecream #niacinamideskincare #glowingskin #kbeauty #antiagingcream #radiantskin #makeupbase #skincaretoneup #moisturizingcream #plantbasedskincare #skinlightening #skinclarity #dailycream #facialbrightening #skinfirming #hydratingskincare #veganbeauty #elasticityboost #multipurposecream #eveningskincare #glutathioneskincare #beautyboxkorea #koreancosmetics #skincareproduct #brightenandfirm #BBK #KoreanMakeup #Kbeauty #Koreancosmetics #Koreanskincare #Koreancosmeticsonline #AsianBeauty #BeautyBoxKorea #Beauty_Box_Korea @beautyboxkorea Payment We accept the following forms of payment: PayPal Payment via PayPal account or international credit/debit cards

Copyright: 2024, Chen et al
As a result, there is variability in the recommendations on how to define high-risk people with diabetes, to whom these disease-modifying agents should be prescribed to have the greatest benefit/impact
2021;54(12):e13142